Wimmy is a South African startup with a mission to provide Winning Insights and Models for Marvellous Yields. The company specializes in data science health analysis, offering predictive diagnosis of occupational health and public health disease prevention. Wimmy's comprehensive approach integrates advanced mathematical and statistical predictive diagnostic models and tools with epidemiology, predictive analytics, causal analytics, artificial intelligence, and machine learning to address health problems. Founded in 2020, Wimmy has established itself as a leader in the Health Care and Information Technology industries, with a headquarters in Cape Town, South Africa and satellite offices in Brussels, Belgium. The startup guides organizations across private and public sectors in their data analytics journey, offering support in various areas from data discovery to validation. Wimmy's expertise extends to workplace injuries, exposure to potential negative health elements, communicable and non-communicable diseases, and general health through healthy lifestyle choices. By providing actionable insights and quantitative measurements, Wimmy helps organizations quantify improvements from health interventions introduced. As of now, the company has not disclosed its latest investment details. With its innovative approach and focus on improving workforce well-being, Wimmy is poised to make significant contributions in the intersection of data science and healthcare.
There is no investment information
No recent news or press coverage available for Wimmy.